The risk of developing cancer increases with age. Factors like smoking and regular aspirin use also affect the risk of cancer – although in the opposite sense. Researchers from the University of Basel were now able to show that aspirin use and smoking both influence aging processes of the female genome that are connected to colorectal cancer. The Journal of the National Cancer Institute has published their results.
Already in the 1990s, scientists discovered that regular use of aspirin over long periods of time decreases the cancer risk. Since then, numerous studies have confirmed the protective effect of the drug against different types of cancer. Regular aspirin use is said to reduce the risk to develop colorectal cancer by an average of 40%. However, it is unknown how exactly the drug influences the cancer risk.
Our lifestyle choices affect the aging processes of our genome which can cause cell transformation and cancer
(Fig.: Martin Oeggerli / Micronaut, in cooperation with FHNW.)
A research group led by Prof. Primo Schär, molecular geneticists at the Department of Biomedicine from the University of Basel and gastrointestinal specialist PD Dr. Kaspar Truninger, has now discovered a possible mechanism of how aspirin decreases the risk of cancer: It slows down certain aging processes of the genome - namely modifications that also play an important role in the development of tumors.
In order to analyze the relationships between lifestyle and genome aging, the researchers examined intestinal tissue samples of 546 healthy women over 50 years of age. They compared age-specific changes of gene markers, so-called DNA methylations, with the women's lifestyle factors regarding aspirin use, smoking, body mass index and hormonal replacement therapy. The most significant effects were measured for aspirin use and smoking.
“Each cell's genome resembles a library that is full of bookmarks”, explains Schär. Thanks to these bookmarks, the cells know which genes to read, so that they can fulfill their specialized tasks as skin, muscle or intestinal cells. “But these markers are not very stable and change during the course of age. If, at certain parts of the genome, the change is to drastic, tumors can develop”, says Schär.
In this study, the researchers were able to show for the first time that this age-related decay of gene markers can be slowed down by the regular use of aspirin. Smoking on the other hand, accelerates the aging process. “Especially affected are genes that also play a role in the development of cancer”, says Dr. Faiza Noreen, research associate at the Department of Biomedicine from the University of Basel and first author of the study.
Truninger emphasizes that it would be premature to start taking aspirin solely for cancer prevention without consulting a doctor first – especially when regarding the potential side effects such as gastrointestinal bleeding.
Noreen F, Röösli M, Gaj P, Pietrzak J, Weis S, Urfer P, Regula J, Schär P and Truninger K.
Modulation of Age- and Cancer Associated DNA Methylation Change in the Healthy Colon by Aspirin and Lifestyle.
Journal of the National Cancer Institute published online, 2014 106 (4): dju161 doi: 10.1093/jnci/dju161
Prof. Primo Schär, Department of Biomedicine, University of Basel, phone: +41 (0)61 267 07 67, email: email@example.com
Olivia Poisson | Universität Basel
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy